Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TUBGCP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF330 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALML4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOB1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2AH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DCUN1D4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANGEL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISCA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC35B3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LYRM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTR2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on